EP 41

CAR T Cell Therapy

CAR T cell therapy is a revolutionary treatment that uses a patient's own immune cells to fight cancer. It has shown remarkable success in treating blood cancers, but its high cost and complexity make it inaccessible to many. Researchers are working to improve the therapy and make it more affordable.

CAR T cell therapyimmunotherapycancer treatmentblood cancerssolid tumors

play_arrowListen to episode

Key Concepts

CAR T Cell Structure

The CAR T cell structure consists of four main components: the extracellular antigen recognition domain, the flexible connection piece, the transmembrane domain, and the intracellular signaling endodomains
The extracellular antigen recognition domain is responsible for recognizing and binding to cancer cells
The flexible connection piece provides the necessary spacing for the antigen recognition domain to properly engage the target
The transmembrane domain anchors the CAR T cell structure in the cell membrane
The intracellular signaling endodomains provide the necessary signals for T cell activation and proliferation

CAR T Cell Therapy Generations

First-generation CAR T cells used a single CD3 domain and were unable to provide a co-stimulatory signal
Second-generation CAR T cells used a CD3 domain and a co-stimulatory domain, such as CD28 or 4-1BB, and were able to provide a co-stimulatory signal
Third-generation CAR T cells used a CD3 domain and two co-stimulatory domains, but were found to be less effective and more toxic
Fourth-generation CAR T cells, also known as TRUX, use a standard second-generation CAR T cell structure with an additional inducible gene expression cassette
Fifth-generation CAR T cells and beyond are focused on precision control and use logic-gated CARs to improve specificity and safety

Autologous vs Allogeneic CAR T Cell Therapy

Autologous CAR T cell therapy uses a patient's own T cells, which are collected, genetically modified, and reinfused into the patient
Allogeneic CAR T cell therapy uses donor T cells, which are genetically modified and infused into the patient
Autologous CAR T cell therapy has a lower risk of graft-versus-host disease, but is more expensive and time-consuming
Allogeneic CAR T cell therapy has a higher risk of graft-versus-host disease, but is potentially more scalable and cost-effective

CAR T Cell Therapy Challenges

One of the main challenges in CAR T cell therapy is the risk of severe side effects, such as cytokine release syndrome
Another challenge is the high cost and complexity of the therapy, which makes it inaccessible to many patients
The therapy is still in the early stages of development, and more research is needed to fully understand its potential and limitations
The therapy is typically used as a last resort for patients who have failed other treatments

CAR T Cell Therapy Future Directions

Researchers are working to improve the therapy and make it more affordable
One area of research is focused on developing more effective and safer CAR T cell structures
Another area of research is focused on developing more effective and safer co-stimulatory domains
The therapy has the potential to be used to treat a wide range of cancers, including solid tumors

Episode Summary

check_circleCAR T cell therapy is a type of immunotherapy that uses a patient's own T cells to fight cancer
check_circleThe therapy involves genetically modifying T cells to recognize and attack cancer cells
check_circleCAR T cell therapy has shown remarkable success in treating blood cancers, such as leukemia and lymphoma
check_circleThe therapy is highly complex and expensive, making it inaccessible to many patients
check_circleResearchers are working to improve the therapy and make it more affordable
check_circleOne of the main challenges in CAR T cell therapy is the risk of severe side effects, such as cytokine release syndrome
check_circleThe therapy is typically used as a last resort for patients who have failed other treatments
check_circleCAR T cell therapy has the potential to be used to treat a wide range of cancers, including solid tumors
check_circleThe therapy is still in the early stages of development, and more research is needed to fully understand its potential and limitations

Full Transcript

Discussion

Join the discussion — sign in to leave a comment.